VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 8, 2015) - Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(WKN:A1C4WM)(OTCQB:ACBFF) ("Aurora" or the "Company") is pleased to announce the appointment of Mr. Neil Belot as Chief Brand Officer ("CBO"). As CBO, Mr. Belot is a member of the Company's senior executive team and is responsible for stewarding the Company's brand image, promise, and client experience while creating new business opportunities consistent with maintaining and raising the Aurora Standard.

Mr. Belot has a BBA from Acadia University in Wolfville, Nova Scotia, a finance-focused MBA from Dalhousie University in Halifax, Nova Scotia, an international MBA exchange with Copenhagen Business School in Denmark, and a certificate in Energy Derivatives, Markets, Instruments and Hedging from the Oxford Princeton Programme.

In joining Aurora, Mr. Belot resigned his position as the inaugural Executive Director of the Canadian Medical Cannabis Industry Association ("CMCIA") - the medical cannabis industry's trade association for Licensed Producers ("LPs") under Health Canada's Marihuana for Medical Purposes Regulations ("MMPR"). In addition to leading CMCIA's advocacy work and lobbying efforts, Mr. Belot also acted as the industry association's primary point of contact for the media, regulators, patient organizations, partners, and other key stakeholders.

Previously, Mr. Belot served on the board of directors for a patient-focused national charity called the Canadian Transverse Myelitis Association, was a public servant in several ministries within the Ontario government and was the Gas Portfolio and Energy Services Manager with Housing Services Corp, managing one of North America's largest group energy hedging, procurement, and energy services programs.

Mr. Belot's intimate understanding of the challenges that people who use cannabis for medical purposes face, stem from his own experiences with a rare spinal disease, that among other things, has given him a passion for the ethical growth and development of the medical cannabis industry in Canada. "It is an honor to be Aurora's Chief Brand Officer and a pleasure to be a part of the forward thinking team of visionaries Terry has assembled. I look forward to helping Aurora exceed the expectations of all those who entrust us with their cannabinoid needs and elevating the standards for client experiences in this new industry," said Mr. Belot.

Terry Booth, CEO of Aurora, commented, "We are extremely pleased to have Neil join Aurora. Neil was being sought after by a number of Licensed Producers and choosing Aurora not only makes us proud but once again re-affirms that Aurora is on the right track in becoming a global leader in this burgeoning Cannabis industry. Neil is one of those rare individuals that possesses the skills and experience needed to deliver on our goals and to help us establish the Aurora Standard."

About Aurora Cannabis Inc.

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada. Aurora's wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market. Aurora is trading on the Canadian Securities Exchange under the trading symbol "ACB".

On behalf of the Board of Directors,


Terry Booth, CEO

The CSE, securities commission or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.

Contact Information:

Aurora Cannabis Inc.
Nilda Rivera
Investor Relations
Toll Free: 1-844-928-7672